US 8404244
Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies
granted A61KA61K2039/5258A61K2039/53
Quick answer
US patent 8404244 (Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/5258, A61K2039/53, A61K2039/55566, A61K2039/58